@article{oai:repo.qst.go.jp:00048598,
 author = {Isozaki, Yuka and Yamada, Shigeru and Kawashiro, Shohei and Yasuda, Shigeo and Okada, Naomi and Ebner, Daniel and Tsuji, Hiroshi and Kamada, Tadashi and 磯崎 由佳 and 山田 滋 and 川城 壮平 and 安田 茂雄 and 岡田 直美 and エブナー ダニエル and 辻 比呂志 and 鎌田 正},
 issue = {7},
 journal = {Journal of surgical oncology},
 month = {Jul},
 note = {BACKGROUND: The safety and effectiveness of carbon-ion radiotherapy (CIRT) for isolated para-aortic lymph node (PALN) metastasis was evaluated retrospectively.
METHODS: CIRT for isolated PALN metastasis from CRC was performed in 34 cases from June 2006 to August 2015 in our institute. A median dose of 52.8 Gy(RBE) (range, 48-52.8 Gy(RBE)) was delivered with a median daily dose of 4.4 Gy(RBE) (range, 4.0-4.4 Gy(RBE)).
RESULTS: The median follow-up duration for all patients was 24.4 months (range, 7-82.8 months). There were 13 cases (38.2%) who achieved complete response after treatment. The local control rates at 2 and 3 years were 70.1% and 70.1%, respectively. The overall survival rates at 2 and 3 years were 83.3% and 63.0%, respectively. The 3-year survival rates for Stage I-III were 68.7%, while those for Stage IV was 0%. The overall survival of cases with rectal cancer or with high CA19-9 values pre-CIRT tended to be worse. The median survival period was 41.7 months. Twelve of the 34 patients survived for more than 3 years. There were no adverse effects of Grade 3 or higher.
CONCLUSIONS: CIRT for isolated PALN recurrence after curative resection for CRC appears effective and safe, and it is considered a promising therapy.},
 pages = {932--938},
 title = {Carbon-ion radiotherapy for isolated para-aortic lymph node recurrence from colorectal cancer.},
 volume = {116},
 year = {2017}
}